A Michigan Medicine study found that most patients with mild COVID-19 infections produce antibodies that persist and protect them from reinfection for up to six months. Researchers analyzed nearly 130...

Abpro Corporation announced it has completed dosing all subjects in a Phase 1 clinical trial evaluating the safety of ABP 300, a human neutralizing antibody for the treatment of COVID-19 derived from patients...

On Tuesday, Vir Biotechnology & GSK announced the COMET-ICE study evaluating VIR-7831, a fully human anti-SARS-CoV-2 monoclonal antibody, will continue into Phase 3 based on an Independent Data Monitoring...

An antibody test for the virus that causes COVID-19, developed by researchers at The University of Texas at Austin in collaboration with Houston Methodist and other institutions, is more accurate and can...

Sweden’s Public Health Authority has launched a survey to measure and estimate how many in the community have had COVID-19. Blood samples are collected from laboratories in clinical chemistry and...

Starting Tuesday, Quest Diagnostics announced individuals can purchase COVID-19 antibody testing for themselves online, without visiting a doctor’s office, through QuestDirect, the consumer-initiated...

Biotechnology company advancing transformative antibody drugs for infectious diseases, transplant rejection and checkpoint resistant cancers, GigaGen, announced today it has been developing a recombinant...